Laser Treatment of Genito-urinary Syndrome in Women
Key facts
- Who runs it
- Herning Hospital
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 1 Oct 2022
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 8 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Vaginal laser treatment
- sham
- laser system
- Record updated
- 16 October 2024
- Why it stopped
- Hospital terminated treatment with laser
Who can take part
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- menopause i.e. age more than 50 years and absence of menstruation for twelve months
- breast cancer
- endometrial cancer
- symptoms of vaginal dryness
- dyspareunia rated as moderate or severe most bothersome symptoms
Who cannot take part
- use of vaginal moisturizers, lubricants or any other local preparation within the thirty days prior to inclusion
- previous reconstructive pelvic surgery
- acute or recurrent urinary tract infections
- active genital infections i.e. herpes genitalis, candida
- any serious disease or chronic condition that could interfere with study compliance except from breast and endometrial cancer
- psychiatric disorders precluding informed consent
- pelvis organ prolapse stage 2
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Women with genitourinary syndrome of menopause, overactive bladder, with breast or endometrial cancer are randomized to either laser treatment og sham treatment for 3 months. The randomization is stratified for estrogen treatment. The effect is evaluated by questionnaire, histology and microbiology swaps
The 8 groups in the trial
- Menopausal LaserExisting treatment, for comparison
20 women with vaginal laser treatment
Treatment: Vaginal laser treatment and laser system
- Menopausal shamSham treatment, for comparison
20 women with probe, no active laser ray
Treatment: sham
- breast cancer laserExisting treatment, for comparison
20 women with breast cancer with vaginal laser treatment
Treatment: Vaginal laser treatment and laser system
- breast cancer shamSham treatment, for comparison
20 women with breast cancer with vaginal probe, no active laser rays
Treatment: sham
- endometrial cancer laserExisting treatment, for comparison
20 women with endometrial cancer with vaginal laser treatment
Treatment: Vaginal laser treatment and laser system
- endometrial cancer shamSham treatment, for comparison
20 women with endometrial cancer with vaginal probe, no active laser rays
Treatment: sham
- overactive bladder laserExisting treatment, for comparison
20 women with overactive bladder with vaginal laser treatment
Treatment: Vaginal laser treatment and laser system
- Overactive bladder shamSham treatment, for comparison
20 women with overactive bladder with vaginal probe, no active laser rays
Treatment: sham
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Laser Treatment of Genito-urinary Syndrome in Women With Breast and Endometrial Cancer and Menopausal Women
- Record updated
- 16 October 2024